Gemcitabine as a Single Agent in the Maintenance Chemotherapy of Patients With Metastatic Breast Cancer
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: Stage IIIB, IV, Recurrent, and Metastatic Breast Cancer|Gemcitabine|Maintenance Chemotherapy
Sponsor: Xijing Hospital
Collaborators: Eli Lilly and Company